Thursday, February 19, 2015

Actavis to Sell $8.4 Billion in Shares to Fund Allergan Acquisition

Actavis it plans to sell $8.4 billion in shares to fund its planned acquisition of Botox maker Allergan.



from WSJ.com: US Business http://ift.tt/1BqjCSU

via IFTTT

No comments:

Post a Comment